ClinicalTrials.Veeva

Menu

Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction

The Washington University logo

The Washington University

Status

Begins enrollment this month

Conditions

Breast Reconstruction
Deep Inferior Epigastric Perforator
Breast Reconstruction After Mastectomy

Treatments

Device: Restrata®

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT07851415
26-X358

Details and patient eligibility

About

This prospective single-arm pilot study will evaluate the application of meshed 5 × 7 cm Restrata® sheets to the abdominal wall donor site following deep inferior epigastric perforator (DIEP) or abdominal wall autologous free tissue transfer in 20 eligible patients.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled for DIEP or abdominal wall autologous free tissue transfer procedure.
  • At least 18 years of age.
  • Karnofsky performance status ≤ 80%
  • Ability to understand and willingness to sign an IRB approved written informed consent document.

Exclusion criteria

  • Current smoker.

  • Body mass index > 39.9.

  • Received systemic chemotherapy within 4 weeks prior to the scheduled DIEP or abdominal wall autologous free tissue transfer procedure.

  • Uncontrolled diabetes mellitus determined by the investigator.

    *Note: if there is documentation of HgbA1c > 12% within 3 months of the scheduled DIEP or abdominal wall autologous free tissue transfer procedure, it will need to be reviewed by the PI to determine the patient's clinical situation and eligibility.

  • Pregnant.

  • Currently receiving any investigational agents.

  • Known sensitivity to resorbable sutures (polyglactin 910, polydioxanone).

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Restrata® application
Experimental group
Description:
Patients undergoing standard of care deep inferior epigastric perforator (DIEP) or abdominal wall free tissue transfer procedure will have Restrata® sheets applied to the abdominal wall donor site following flap harvest. Patients will be followed for 12 months to assess outcomes.
Treatment:
Device: Restrata®

Trial contacts and locations

1

Loading...

Central trial contact

Justin Sacks, MD, MBA, FACS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems